 |
2 Diseases |  |
0 Trials |
|
0 Trials |  |
6 News |  |
- || MIV 710 / Medivir, MIV-711 / Medivir
New P1 trial: A Bioavailability Study of MIV-711 Oral Formulations in Healthy Volunteers (clinicaltrials.gov) - Jul 15, 2018
P1, N=18, Completed, Sponsor: Medivir
- | MIV 710 / Medivir, MIV-711 / Medivir
Trial completion: A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients (clinicaltrials.gov) - Dec 28, 2017
P2, N=50, Completed, Sponsor: Medivir
Active, not recruiting --> Completed
- |||| MIV 710 / Medivir, MIV-711 / Medivir
Trial completion: A Study to Evaluate the Efficacy, Safety and Tolerability of MIV-711 in Osteoarthritis Patients (clinicaltrials.gov) - Aug 25, 2017
P2a, N=244, Completed, Sponsor: Medivir
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | MIV 710 / Medivir, MIV-711 / Medivir
Enrollment closed, Enrollment change: A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients (clinicaltrials.gov) - Aug 25, 2017
P2, N=50, Active, not recruiting, Sponsor: Medivir
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=80 --> 50
- ||| MIV 710 / Medivir, MIV-711 / Medivir
Enrollment closed: A Study to Evaluate the Efficacy, Safety and Tolerability of MIV-711 in Osteoarthritis Patients (clinicaltrials.gov) - Dec 23, 2016
P2a, N=244, Active, not recruiting, Sponsor: Medivir
Recruiting --> Active, not recruiting | N=80 --> 50 Recruiting --> Active, not recruiting
- ||||| MIV 710 / Medivir, MIV-711 / Medivir
New P2a trial: A Study to Evaluate the Efficacy, Safety and Tolerability of MIV-711 in Osteoarthritis Patients (clinicaltrials.gov) - Mar 10, 2016
P2a, N=240, Recruiting, Sponsor: Medivir